Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Extended single-dose toxicity study of [211At]NaAt in mice for the first-in-human clinical trial of targeted alpha therapy for differentiated thyroid cancer.
Watabe T, Kaneda-Nakashima K, Ooe K, Liu Y, Kurimoto K, Murai T, Shidahara Y, Okuma K, Takeuchi M, Nishide M, Toyoshima A, Shinohara A, Shirakami Y. Watabe T, et al. Among authors: ooe k. Ann Nucl Med. 2021 Jun;35(6):702-718. doi: 10.1007/s12149-021-01612-9. Epub 2021 Apr 19. Ann Nucl Med. 2021. PMID: 33871803 Free PMC article.
Targeted α-therapy using astatine (211At)-labeled PSMA1, 5, and 6: a preclinical evaluation as a novel compound.
Watabe T, Kaneda-Nakashima K, Shirakami Y, Kadonaga Y, Ooe K, Wang Y, Haba H, Toyoshima A, Cardinale J, Giesel FL, Tomiyama N, Fukase K. Watabe T, et al. Among authors: ooe k. Eur J Nucl Med Mol Imaging. 2023 Feb;50(3):849-858. doi: 10.1007/s00259-022-06016-z. Epub 2022 Nov 8. Eur J Nucl Med Mol Imaging. 2023. PMID: 36344651 Free PMC article.
Immuno-PET and Targeted α-Therapy Using Anti-Glypican-1 Antibody Labeled with 89Zr or 211At: A Theranostic Approach for Pancreatic Ductal Adenocarcinoma.
Watabe T, Kabayama K, Naka S, Yamamoto R, Kaneda K, Serada S, Ooe K, Toyoshima A, Wang Y, Haba H, Kurimoto K, Kobayashi T, Shimosegawa E, Tomiyama N, Fukase K, Naka T. Watabe T, et al. Among authors: ooe k. J Nucl Med. 2023 Dec 1;64(12):1949-1955. doi: 10.2967/jnumed.123.266313. J Nucl Med. 2023. PMID: 37827841 Free PMC article.
87 results